{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:27:09Z","timestamp":1783351629339,"version":"3.54.6"},"reference-count":131,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council\/United Kingdom","doi-asserted-by":"publisher","award":["MR\/M018237\/1\/MRC"],"award-info":[{"award-number":["MR\/M018237\/1\/MRC"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council\/United Kingdom","doi-asserted-by":"publisher","award":["MR\/T031921\/1\/MRC"],"award-info":[{"award-number":["MR\/T031921\/1\/MRC"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council\/United Kingdom","doi-asserted-by":"publisher","award":["FS\/CRTF\/22\/24361"],"award-info":[{"award-number":["FS\/CRTF\/22\/24361"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council\/United Kingdom","doi-asserted-by":"publisher","award":["PG\/20\/10187"],"award-info":[{"award-number":["PG\/20\/10187"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["MR\/M018237\/1\/MRC"],"award-info":[{"award-number":["MR\/M018237\/1\/MRC"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["MR\/T031921\/1\/MRC"],"award-info":[{"award-number":["MR\/T031921\/1\/MRC"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CRTF\/22\/24361"],"award-info":[{"award-number":["FS\/CRTF\/22\/24361"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/20\/10187"],"award-info":[{"award-number":["PG\/20\/10187"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The renin angiotensin aldosterone system is a key regulator of blood pressure. Aldosterone is the final effector of this pathway, acting predominantly via mineralocorticoid receptors. Aldosterone facilitates the conservation of sodium and, with it, water and acts as a powerful stimulus for potassium excretion. However, evidence for the pathological impact of excess mineralocorticoid receptor stimulation is increasing. Here, we discussed how in the heart, hyperaldosteronism is associated with fibrosis, cardiac dysfunction, and maladaptive hypertrophy. In the kidney, aldosterone was shown to cause proteinuria and fibrosis and may contribute to the progression of kidney disease. More recently, studies suggested that aldosterone excess damaged endothelial cells. Here, we reviewed how damage to the endothelial glycocalyx may contribute to this process. The endothelial glycocalyx is a heterogenous, negatively charged layer on the luminal surface of cells. Aldosterone exposure alters this layer. The resulting structural changes reduced endothelial reactivity in response to protective shear stress, altered permeability, and increased immune cell trafficking. Finally, we reviewed current therapeutic strategies for limiting endothelial damage and suggested that preventing glycocalyx remodelling in response to aldosterone exposure may provide a novel strategy, free from the serious adverse effect of hyperkalaemia seen in response to mineralocorticoid blockade.<\/jats:p>","DOI":"10.3390\/biom13061004","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T01:31:14Z","timestamp":1687138274000},"page":"1004","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Aldosterone: Essential for Life but Damaging to the Vascular Endothelium"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6463-9020","authenticated-orcid":false,"given":"Michael","family":"Crompton","sequence":"first","affiliation":[{"name":"Bristol Renal, Dorothy Hodgkin Building, University of Bristol, Whitson Street, Bristol BS1 3NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Skinner","sequence":"additional","affiliation":[{"name":"Bristol Renal, Dorothy Hodgkin Building, University of Bristol, Whitson Street, Bristol BS1 3NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Satchell","sequence":"additional","affiliation":[{"name":"Bristol Renal, Dorothy Hodgkin Building, University of Bristol, Whitson Street, Bristol BS1 3NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Butler","sequence":"additional","affiliation":[{"name":"Bristol Renal, Dorothy Hodgkin Building, University of Bristol, Whitson Street, Bristol BS1 3NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/physrev.00011.2014","article-title":"Epithelial sodium transport and its control by aldosterone: The story of our internal environment revisited","volume":"95","author":"Rossier","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1172\/JCI107414","article-title":"Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism","volume":"52","author":"Kem","year":"1973","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/endo-99-2-567","article-title":"Circadian rhythms of serum renin activity and serum corticosterone, prolactin, and aldosterone concentrations in the male rat on normal and low-sodium diets","volume":"99","author":"Holland","year":"1976","journal-title":"Endocrinology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhh.2014.11","article-title":"Endothelial dysfunction in patients with primary aldosteronism: A biomarker of target organ damage","volume":"28","author":"Liu","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","article-title":"Pathogenesis and treatment of primary aldosteronism","volume":"16","author":"Zennaro","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: Clinical relevance for resistant hypertension","volume":"25","author":"Shibata","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ki.2008.429","article-title":"Renal injury in extreme obesity: The important role of aldosterone","volume":"74","author":"Bomback","year":"2008","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10157-010-0298-8","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome","volume":"14","author":"Nagase","year":"2010","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1470320309352353","article-title":"Disordered aldosterone-volume relationship in end-stage kidney disease","volume":"10","author":"Bomback","year":"2009","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11906-010-0135-1","article-title":"The impact of obstructive sleep apnea on chronic kidney disease","volume":"12","author":"Adeseun","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.ajkd.2011.08.032","article-title":"Self-reported sleep duration and prediction of proteinuria: A retrospective cohort study","volume":"59","author":"Yamamoto","year":"2012","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"The Adipocyte-Derived Hormone Leptin is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"161396","DOI":"10.1155\/2013\/161396","article-title":"Rapid induction of aldosterone synthesis in cultured neonatal rat cardiomyocytes under high glucose conditions","volume":"2013","author":"Fujisaki","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mce.2011.06.026","article-title":"Non-adrenal synthesis of aldosterone: A reality check","volume":"350","author":"MacKenzie","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.113.007690","article-title":"Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis","volume":"130","author":"Maron","year":"2014","journal-title":"Circulation"},{"key":"ref_19","first-page":"2797","article-title":"Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin","volume":"81","author":"Takeda","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/en.2004-0081","article-title":"Do human vascular endothelial cells produce aldosterone?","volume":"145","author":"Ahmad","year":"2004","journal-title":"Endocrinology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: Implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/ALN.0000000000003127","article-title":"Aldosterone Synthase in Peripheral Sensory Neurons Contributes to Mechanical Hypersensitivity during Local Inflammation in Rats","volume":"132","author":"Mohamed","year":"2020","journal-title":"Anesthesiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-2143(03)00062-3","article-title":"Aldosteronism revisited: Perspectives on less well-recognized actions of aldosterone","volume":"142","author":"Weber","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11883-013-0340-x","article-title":"Mineralocorticoid receptors in vascular disease: Connecting molecular pathways to clinical implications","volume":"15","author":"McGraw","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.113.01967","article-title":"Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness","volume":"63","author":"Galmiche","year":"2014","journal-title":"Hypertension"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11906-014-0427-y","article-title":"Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: Novel mechanisms and clinical implications","volume":"16","author":"Koenig","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00424-014-1616-x","article-title":"Role of smooth muscle cell mineralocorticoid receptor in vascular tone","volume":"467","author":"Tarjus","year":"2015","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_28","first-page":"4544","article-title":"Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target","volume":"29","author":"Chadwick","year":"2015","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2014.11.004","article-title":"Aldosterone up-regulates MMP-9 and MMP-9\/NGAL expression in human neutrophils through p38, ERK1\/2 and PI3K pathways","volume":"331","author":"Gilet","year":"2015","journal-title":"Exp. Cell. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/HYPERTENSIONAHA.115.06015","article-title":"Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females","volume":"66","author":"Jia","year":"2015","journal-title":"Hypertension"},{"key":"ref_31","first-page":"2454","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Loufrani","year":"2010","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/HYPERTENSIONAHA.110.164558","article-title":"Stiff endothelial cell syndrome in vascular inflammation and mineralocorticoid excess","volume":"57","author":"Lang","year":"2011","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","article-title":"Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure","volume":"63","author":"Rickard","year":"2014","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mce.2011.05.029","article-title":"Transcriptome analysis of aldosterone-regulated genes in human vascular endothelial cell lines stably expressing mineralocorticoid receptor","volume":"341","author":"Sekizawa","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20130050","article-title":"Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: A focus on the cardiomyocyte","volume":"125","author":"Bienvenu","year":"2013","journal-title":"Clin. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-pharmtox-010814-124302","article-title":"Mineralocorticoids in the heart and vasculature: New insights for old hormones","volume":"55","author":"Lother","year":"2015","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-15-0122","article-title":"Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology","volume":"55","author":"Armani","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kint.2018.08.024","article-title":"Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx","volume":"95","author":"Butler","year":"2019","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/HYPERTENSIONAHA.114.00002","article-title":"Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by microRNA","volume":"64","author":"Rezaei","year":"2014","journal-title":"Hypertension"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"bvab146","DOI":"10.1210\/jendso\/bvab146","article-title":"11betaHSD2 Efficacy in Preventing Transcriptional Activation of the Mineralocorticoid Receptor by Corticosterone","volume":"5","author":"Ali","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe\u2212\/\u2212 mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.115.05262","article-title":"Mineralocorticoid Excess or Glucocorticoid Insufficiency: Renal and Metabolic Phenotypes in a Rat Hsd11b2 Knockout Model","volume":"66","author":"Mullins","year":"2015","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvn231","article-title":"Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression","volume":"81","author":"Liu","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI4445","article-title":"Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2","volume":"103","author":"Kotelevtsev","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_45","first-page":"3745","article-title":"Molecular basis of human salt sensitivity: The role of the 11beta-hydroxysteroid dehydrogenase type 2","volume":"84","author":"Lovati","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/JOE-12-0200","article-title":"Uninephrectomy reduces 11beta-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats","volume":"214","author":"Lauterburg","year":"2012","journal-title":"J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e00101","DOI":"10.1002\/phy2.101","article-title":"Evidence for glucocorticoid-mediated hypertension after uninephrectomy","volume":"1","author":"Huesler","year":"2013","journal-title":"Physiol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/eje.1.01954","article-title":"Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function","volume":"153","author":"Quinkler","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0032-1321851","article-title":"11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension","volume":"44","author":"Melcescu","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"ref_50","first-page":"3618","article-title":"Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: Functional characterization and relevance for salt sensitivity","volume":"21","author":"Fouladkou","year":"2007","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0b013e328360c200","article-title":"Evolving research in nongenomic actions of aldosterone","volume":"20","author":"Williams","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: From receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1093\/emboj\/20.24.7052","article-title":"Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression","volume":"20","author":"Debonneville","year":"2001","journal-title":"EMBO J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00424-008-0615-1","article-title":"Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor","volume":"458","author":"Wildling","year":"2009","journal-title":"Pflug. Arch."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/JOE-10-0458","article-title":"Dietary sodium intake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling proteins in heart","volume":"211","author":"Ricchiuti","year":"2011","journal-title":"J. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbamcr.2010.02.008","article-title":"Colocalization of mineralocorticoid and EGF receptor at the plasma membrane","volume":"1803","author":"Grossmann","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/ME.2014-1410","article-title":"Role of Nongenomic Signaling Pathways Activated by Aldosterone during Cardiac Reperfusion Injury","volume":"29","author":"Ashton","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.tem.2015.05.005","article-title":"Nicolaus Copernicus and the rapid vascular responses to aldosterone","volume":"26","author":"Barton","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18632\/oncotarget.6475","article-title":"GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells","volume":"7","author":"Rigiracciolo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1210\/jc.2019-00043","article-title":"Aldosterone Stimulates Its Biosynthesis Via a Novel GPER-Mediated Mechanism","volume":"104","author":"Caroccia","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","article-title":"Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation","volume":"304","author":"Gros","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/1440-1681.12125","article-title":"Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation","volume":"40","author":"Barrett","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"117211","DOI":"10.1016\/j.lfs.2019.117211","article-title":"The activation of the G protein-coupled estrogen receptor (GPER) prevents and regresses cardiac hypertrophy","volume":"242","author":"Mariangelo","year":"2020","journal-title":"Life Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1681\/ASN.2012010017","article-title":"Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction","volume":"23","author":"Salmon","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00424-011-0999-1","article-title":"Salt overload damages the glycocalyx sodium barrier of vascular endothelium","volume":"462","author":"Oberleithner","year":"2011","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4330\/wjc.v6.i8.824","article-title":"Is reversal of endothelial dysfunction still an attractive target in modern cardiology?","volume":"6","author":"Mordi","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF00429099","article-title":"Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"35","author":"McVeigh","year":"1992","journal-title":"Diabetologia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199601183340303","article-title":"Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults","volume":"334","author":"Celermajer","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","article-title":"Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults","volume":"88","author":"Celermajer","year":"1993","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199007053230105","article-title":"Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"323","author":"Panza","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.HYP.0000184231.84465.62","article-title":"Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation","volume":"46","author":"Duffy","year":"2005","journal-title":"Hypertension"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jch.13585","article-title":"Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction","volume":"21","author":"Demirkiran","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.amjcard.2004.03.015","article-title":"Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy","volume":"93","author":"Abiose","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.ajkd.2018.12.037","article-title":"Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial","volume":"74","author":"Nowak","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Zeng, Y., and Tarbell, J.M. (2014). The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086249"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Yen, W., Cai, B., Yang, J., Zhang, L., Zeng, M., Tarbell, J.M., and Fu, B.M. (2015). Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117133"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-bioeng-071813-104908","article-title":"Mechanosensing at the vascular interface","volume":"16","author":"Tarbell","year":"2014","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.kint.2019.09.035","article-title":"Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease","volume":"97","author":"Ramnath","year":"2020","journal-title":"Kidney Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/HYPERTENSIONAHA.111.196832","article-title":"Aldosterone modulates endothelial permeability and endothelial nitric oxide synthase activity by rearrangement of the actin cytoskeleton","volume":"61","author":"Kirsch","year":"2013","journal-title":"Hypertension"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1242\/jcs.02886","article-title":"Differential action of steroid hormones on human endothelium","volume":"119","author":"Oberleithner","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/path.3964","article-title":"Endothelial glycocalyx dysfunction in disease: Albuminuria and increased microvascular permeability","volume":"226","author":"Salmon","year":"2012","journal-title":"J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e154164","DOI":"10.1172\/jci.insight.154164","article-title":"Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx","volume":"8","author":"Crompton","year":"2023","journal-title":"JCI Insight"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrneph.2013.197","article-title":"The role of the glomerular endothelium in albumin handling","volume":"9","author":"Satchell","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.mnh.0000242172.06459.7c","article-title":"Obesity, proteinuria and progression of renal failure","volume":"15","author":"Praga","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_87","first-page":"CD007004","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease","volume":"4","author":"Bolignano","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: Behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3109\/0886022X.2012.672156","article-title":"Mineralocorticoid receptor antagonist for renal protection","volume":"34","author":"Ma","year":"2012","journal-title":"Ren. Fail."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1470320311412811","article-title":"The long-term antiproteinuric effect of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease","volume":"13","author":"Tsuboi","year":"2012","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/08860220903216121","article-title":"Effect of spironolactone on urinary protein excretion in patients with chronic kidney disease","volume":"31","author":"Sengul","year":"2009","journal-title":"Ren. Fail."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/hr.2011.16","article-title":"Aldosterone\/NaCl-induced renal and cardiac fibrosis is modulated by TGF-beta responsiveness of T cells","volume":"34","author":"Schreier","year":"2011","journal-title":"Hypertens. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00065.2008","article-title":"Regression of glomerulosclerosis in subtotally nephrectomized rats: Effects of monotherapy with losartan, spironolactone, and their combination","volume":"295","author":"Piecha","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"F520","DOI":"10.1152\/ajprenal.00570.2012","article-title":"Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury","volume":"305","author":"Su","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2012111094","article-title":"Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease","volume":"25","author":"Huang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/en.2006-0965","article-title":"A direct effect of aldosterone on endothelin-1 gene expression in vivo","volume":"148","author":"Wong","year":"2007","journal-title":"Endocrinology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000504623","article-title":"The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease","volume":"6","author":"Raina","year":"2020","journal-title":"Kidney Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db15-1413","article-title":"Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy","volume":"65","author":"Boels","year":"2016","journal-title":"Diabetes"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): A double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1161\/HYPERTENSIONAHA.107.099531","article-title":"Aldosterone rapidly induces leukocyte adhesion to endothelial cells: A new link between aldosterone and arteriosclerosis?","volume":"50","author":"Krug","year":"2007","journal-title":"Hypertension"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","article-title":"Essential role of ICAM-1 in aldosterone-induced atherosclerosis","volume":"232","author":"Marzolla","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.115.06530","article-title":"Deoxycorticosterone Acetate\/Salt-Induced Cardiac but not Renal Injury Is Mediated by Endothelial Mineralocorticoid Receptors Independently From Blood Pressure","volume":"67","author":"Lother","year":"2016","journal-title":"Hypertension"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1161\/ATVBAHA.114.303424","article-title":"Mechanoresponsive networks controlling vascular inflammation","volume":"34","author":"Bryan","year":"2014","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0707791104","article-title":"Plasma sodium stiffens vascular endothelium and reduces nitric oxide release","volume":"104","author":"Oberleithner","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurheartj\/ehr176","article-title":"Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure","volume":"33","author":"Ivanes","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvs217","article-title":"Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: Current understanding and remaining questions","volume":"96","author":"Wentzel","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_109","first-page":"7202","article-title":"AMP-activated protein kinase regulates glycocalyx impairment and macrophage recruitment in response to low shear stress","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000106021","article-title":"Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapy","volume":"30","author":"Haddad","year":"2007","journal-title":"Kidney Blood Press. Res."},{"key":"ref_113","first-page":"B4265","article-title":"The renin-angiotensin-aldosterone system and its blockade in diabetic nephropathy: Main focus on the role of aldosterone","volume":"58","author":"Schjoedt","year":"2011","journal-title":"Dan. Med. Bull."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy","volume":"29","author":"Sato","year":"2001","journal-title":"J. Int. Med. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40697-015-0044-y","article-title":"Acute kidney injury: An acceptable risk of treatment with renin-angiotensin system blockade in primary care?","volume":"2","author":"Bedford","year":"2015","journal-title":"Can. J. Kidney Health Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"c1768","DOI":"10.1136\/bmj.c1768","article-title":"Spironolactone use and renal toxicity: Population based longitudinal analysis","volume":"340","author":"Wei","year":"2010","journal-title":"BMJ"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10741-005-2345-1","article-title":"Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis","volume":"10","author":"Sica","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1745-6215-15-160","article-title":"Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: Study protocol for a randomized controlled trial","volume":"15","author":"Hill","year":"2014","journal-title":"Trials"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2015.07.006","article-title":"Pharmacological treatment of aldosterone excess","volume":"154","author":"Deinum","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40262-019-00820-x","article-title":"Population Pharmacokinetic and Exposure-Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease","volume":"59","author":"Snelder","year":"2020","journal-title":"Clin. Pharm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2021070942","article-title":"Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial","volume":"33","author":"Agarwal","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): A multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vascn.2014.09.011","article-title":"Rhesus monkey model for concurrent analyses of in vivo selectivity, pharmacokinetics and pharmacodynamics of aldosterone synthase inhibitors","volume":"71","author":"Cai","year":"2015","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"9382","DOI":"10.1021\/acs.jmedchem.5b01545","article-title":"Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonam ide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects","volume":"58","author":"Papillon","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1021\/acs.jmedchem.8b00328","article-title":"Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2","volume":"61","author":"Sakakibara","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/acsmedchemlett.9b00152","article-title":"Development of Highly Selective Pyrimidine-Based Aldosterone Synthase (CYP11B2) Inhibitors","volume":"10","author":"Sparks","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/6\/1004\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:57:02Z","timestamp":1760126222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/6\/1004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":131,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["biom13061004"],"URL":"https:\/\/doi.org\/10.3390\/biom13061004","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,17]]}}}